Briefly, plasma samples were collected from 64 EGFR exon 19 deletion, 36 EGFR p.L858R mutation, and 53 EGFR wild-type patients in the Department of Lung Cancer and 41 healthy controls from the Physical Examination Centre at our institution. This evidence concerns the gene EGFR and lung carcinoma.